Ortho Clinical Diagnostics determined that biased results may occur for specific VITROS Immunodiagnostic Products (MicroWell Assays) at biotin concentrations which are lower than indicated in the current Instructions for Use (IFU)
Historically, these assays were evaluated for the interference consistent with CLSI document EP7. Biotin was tested and was not found to cause a bias of >/=10%.
To assess the potential interference of biotin supplements on VITROS MicroWell Assays, Ortho performed more robust testing using the new CLSI guidelines EP7 and EP37 and determined that the information in the current IFUs is no longer supported for these five (5) assays. The concentration of biotin that causes >/=10% bias is listed in the customer letter.